Meridian Bioscience Inc. Sets New 1-Year High at $26.91 (VIVO)
Meridian Bioscience (NASDAQ:VIVO) set a new 52-week high during trading on Tuesday, StockRatingsNetwork reports. The stock traded as high as $26.91 and last traded at $26.73, with a volume of 91,941 shares. The stock had previously closed at $26.14.
Meridian Bioscience has a 52-week low of $19.15 and a 52-week high of $26.91. The stock’s 50-day moving average is $25.08 and its 200-day moving average is $23.94. The company has a market cap of $1.114 billion and a price-to-earnings ratio of 28.73.
Meridian Bioscience (NASDAQ:VIVO) last released its earnings data on Thursday, November 7th. The company reported $0.22 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.23 by $0.01. The company had revenue of $48.96 million for the quarter, compared to the consensus estimate of $49.24 million. During the same quarter in the prior year, the company posted $0.21 earnings per share. The company’s quarterly revenue was up 12.6% on a year-over-year basis. Analysts expect that Meridian Bioscience will post $1.00 EPS for the current fiscal year.
Meridian Bioscience, Inc (NASDAQ:VIVO) is a fully-integrated life science company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.